MiMedx - Rasio total nilai perusahaan marang pendapatan MDXG

mimedx.com (MDXG) - logo korporat

MiMedx Group, Inc. (MDXG) develops biomaterials for tissue regeneration, ensuring high margins and free cash flow. Its independence from macroeconomic trends makes the asset defensive. The EV/Sales trajectory visualizes these business proportions, where the current status equals 1096.50. Leadership in the placental drug niche allows the company to exercise pricing power over insurance companies for effective wound treatment.

MDXG MiMedx Group, Inc.: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

MiMedx Corp - rincian analitis lan metrik utama (MDXG)

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:MiMedx Group, Inc.
Produk asil prodhuksi MiMedx Group

A defensive portfolio is constructed through the strict selection of assets with sustainable fundamental value. This metric compares the total enterprise value, including debt, against annual sales volume, neutralizing the impact of the credit load. For MiMedx Group, Inc. (MDXG), dominance in the biologics niche and insurance support justify a premium multiple. The investor assesses the efficiency of revenue capitalization through historical EV/Sales trends, which allows for the determination of whether the asset is overbought.

Analisis pesaing MiMedx Group, Inc.

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan Rezolute Inc RZLT|Multiplikator EV/Sales LXRX|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)